Listed

Lucid Diagnostics Inc.

LUCDNasdaqCIK 1799011HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.5m, Q2 FY2026
Operating income−$12.8m, Q2 FY2026
Net income−$11.7m, Q2 FY2026
Lucid Diagnostics Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.8Revenue, Q3 FY2023, three months to 2023-09-30$783.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure1.0Revenue, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure1.0Revenue, Q1 FY2024, three months to 2024-03-31$1.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure1.0Revenue, Q2 FY2024, three months to 2024-06-30$976.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure1.2Revenue, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure1.2Revenue, Q4 FY2024, three months to 2024-12-31$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure0.8Revenue, Q1 FY2025, three months to 2025-03-31$828.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure1.2Revenue, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure1.2Revenue, Q3 FY2025, three months to 2025-09-30$1.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure1.5Revenue, Q4 FY2025, three months to 2025-12-31$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure1.3Revenue, Q1 FY2026, three months to 2026-03-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure1.5Revenue, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reported1.6Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure1.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figurenot reportednot reported1.6Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure1.4Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Gross profit$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m1.6Research and development, Q3 FY2023, three months to 2023-09-30$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure1.9Research and development, Q4 FY2023, three months to 2023-12-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure1.5Research and development, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure1.4Research and development, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure1.7Research and development, Q3 FY2024, three months to 2024-09-30$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure1.5Research and development, Q4 FY2024, three months to 2024-12-31$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure1.4Research and development, Q1 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure1.3Research and development, Q2 FY2025, three months to 2025-06-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure1.3Research and development, Q3 FY2025, three months to 2025-09-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure1.7Research and development, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure1.2Research and development, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure1.2Research and development, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(11.1)Operating income, Q3 FY2023, three months to 2023-09-30−$11.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure(11.5)Operating income, Q4 FY2023, three months to 2023-12-31−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Operating income, Q1 FY2024, three months to 2024-03-31−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure(11.2)Operating income, Q2 FY2024, three months to 2024-06-30−$11.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure(11.7)Operating income, Q3 FY2024, three months to 2024-09-30−$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure(12.4)Operating income, Q4 FY2024, three months to 2024-12-31−$12.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Operating income, Q1 FY2025, three months to 2025-03-31−$12.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(11.4)Operating income, Q2 FY2025, three months to 2025-06-30−$11.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure(11.8)Operating income, Q3 FY2025, three months to 2025-09-30−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure(14.0)Operating income, Q4 FY2025, three months to 2025-12-31−$14.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Operating income, Q1 FY2026, three months to 2026-03-31−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(12.8)Operating income, Q2 FY2026, three months to 2026-06-30−$12.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$149.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$11.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$12.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$6.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$7.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$9.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$6.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$6.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$6.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$4.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figurenot reportednot reported0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Net income$m(14.2)Net income, Q3 FY2023, three months to 2023-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure(10.8)Net income, Q4 FY2023, three months to 2023-12-31−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure(10.6)Net income, Q1 FY2024, three months to 2024-03-31−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure(11.0)Net income, Q2 FY2024, three months to 2024-06-30−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure(12.4)Net income, Q3 FY2024, three months to 2024-09-30−$12.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure(11.5)Net income, Q4 FY2024, three months to 2024-12-31−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure(26.9)Net income, Q1 FY2025, three months to 2025-03-31−$26.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(4.4)Net income, Q2 FY2025, three months to 2025-06-30−$4.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure(10.4)Net income, Q3 FY2025, three months to 2025-09-30−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure(16.3)Net income, Q4 FY2025, three months to 2025-12-31−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure(13.9)Net income, Q1 FY2026, three months to 2026-03-31−$13.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(11.7)Net income, Q2 FY2026, three months to 2026-06-30−$11.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Diluted EPS$ per share(0.34)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure(0.23)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure(0.25)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figurenot reported(0.52)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure(0.08)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure(0.10)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figurenot reportednot reportednot reported
Basic EPS$ per share(0.34)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figurenot reported(0.40)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure(0.23)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure(0.25)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figurenot reported(0.52)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(0.08)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure(0.10)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figurenot reported(0.17)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(0.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure

Balance sheet

Cash and equivalents$33.4m, Q2 FY2026
Shareholders' equity$10.9m, Q2 FY2026
Lucid Diagnostics Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m24.1Cash and equivalents, Q3 FY2023, at 2023-09-30$24.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001493152-23-040623.Report this figure18.9Cash and equivalents, FY2023, at 2023-12-31$18.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0001641172-25-000205.Report this figure24.8Cash and equivalents, Q1 FY2024, at 2024-03-31$24.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001493152-24-018800.Report this figure24.9Cash and equivalents, Q2 FY2024, at 2024-06-30$24.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0001493152-24-031168.Report this figure14.5Cash and equivalents, Q3 FY2024, at 2024-09-30$14.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure22.4Cash and equivalents, FY2024, at 2024-12-31$22.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure25.2Cash and equivalents, Q1 FY2025, at 2025-03-31$25.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure31.1Cash and equivalents, Q2 FY2025, at 2025-06-30$31.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure47.3Cash and equivalents, Q3 FY2025, at 2025-09-30$47.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure34.7Cash and equivalents, FY2025, at 2025-12-31$34.7m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure27.9Cash and equivalents, Q1 FY2026, at 2026-03-31$27.9m. XBRL concept us-gaap:Cash. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure33.4Cash and equivalents, Q2 FY2026, at 2026-06-30$33.4m. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Current assets$m27.3Current assets, Q3 FY2023, at 2023-09-30$27.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040623.Report this figure22.1Current assets, FY2023, at 2023-12-31$22.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0001641172-25-000205.Report this figure27.6Current assets, Q1 FY2024, at 2024-03-31$27.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018800.Report this figure27.9Current assets, Q2 FY2024, at 2024-06-30$27.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031168.Report this figure16.8Current assets, Q3 FY2024, at 2024-09-30$16.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure25.1Current assets, FY2024, at 2024-12-31$25.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001437749-26-009805.Report this figure27.5Current assets, Q1 FY2025, at 2025-03-31$27.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure33.8Current assets, Q2 FY2025, at 2025-06-30$33.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure49.8Current assets, Q3 FY2025, at 2025-09-30$49.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure37.5Current assets, FY2025, at 2025-12-31$37.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure31.4Current assets, Q1 FY2026, at 2026-03-31$31.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure36.6Current assets, Q2 FY2026, at 2026-06-30$36.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Total assets$m33.2Total assets, Q3 FY2023, at 2023-09-30$33.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001493152-23-040623.Report this figure27.3Total assets, FY2023, at 2023-12-31$27.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0001641172-25-000205.Report this figure32.0Total assets, Q1 FY2024, at 2024-03-31$32.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001493152-24-018800.Report this figure34.1Total assets, Q2 FY2024, at 2024-06-30$34.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001493152-24-031168.Report this figure22.6Total assets, Q3 FY2024, at 2024-09-30$22.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure30.7Total assets, FY2024, at 2024-12-31$30.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001437749-26-009805.Report this figure32.8Total assets, Q1 FY2025, at 2025-03-31$32.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure38.7Total assets, Q2 FY2025, at 2025-06-30$38.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure53.2Total assets, Q3 FY2025, at 2025-09-30$53.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure40.4Total assets, FY2025, at 2025-12-31$40.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure34.1Total assets, Q1 FY2026, at 2026-03-31$34.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure38.9Total assets, Q2 FY2026, at 2026-06-30$38.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Current liabilities$m30.2Current liabilities, Q3 FY2023, at 2023-09-30$30.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040623.Report this figure29.4Current liabilities, FY2023, at 2023-12-31$29.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0001641172-25-000205.Report this figure20.0Current liabilities, Q1 FY2024, at 2024-03-31$20.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018800.Report this figure16.0Current liabilities, Q2 FY2024, at 2024-06-30$16.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031168.Report this figure14.2Current liabilities, Q3 FY2024, at 2024-09-30$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure23.5Current liabilities, FY2024, at 2024-12-31$23.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001437749-26-009805.Report this figure36.6Current liabilities, Q1 FY2025, at 2025-03-31$36.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure29.4Current liabilities, Q2 FY2025, at 2025-06-30$29.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure26.2Current liabilities, Q3 FY2025, at 2025-09-30$26.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure28.6Current liabilities, FY2025, at 2025-12-31$28.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure29.4Current liabilities, Q1 FY2026, at 2026-03-31$29.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure27.5Current liabilities, Q2 FY2026, at 2026-06-30$27.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Total liabilities$m30.7Total liabilities, Q3 FY2023, at 2023-09-30$30.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001493152-23-040623.Report this figure29.6Total liabilities, FY2023, at 2023-12-31$29.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0001641172-25-000205.Report this figure20.2Total liabilities, Q1 FY2024, at 2024-03-31$20.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001493152-24-018800.Report this figure18.1Total liabilities, Q2 FY2024, at 2024-06-30$18.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001493152-24-031168.Report this figure16.3Total liabilities, Q3 FY2024, at 2024-09-30$16.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure25.3Total liabilities, FY2024, at 2024-12-31$25.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001437749-26-009805.Report this figure38.2Total liabilities, Q1 FY2025, at 2025-03-31$38.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure30.8Total liabilities, Q2 FY2025, at 2025-06-30$30.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure27.4Total liabilities, Q3 FY2025, at 2025-09-30$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure29.5Total liabilities, FY2025, at 2025-12-31$29.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure30.1Total liabilities, Q1 FY2026, at 2026-03-31$30.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure28.0Total liabilities, Q2 FY2026, at 2026-06-30$28.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m2.6Shareholders' equity, Q3 FY2023, at 2023-09-30$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure(2.3)Shareholders' equity, FY2023, at 2023-12-31−$2.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001437749-26-009805.Report this figure11.9Shareholders' equity, Q1 FY2024, at 2024-03-31$11.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure16.0Shareholders' equity, Q2 FY2024, at 2024-06-30$16.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure6.3Shareholders' equity, Q3 FY2024, at 2024-09-30$6.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure5.4Shareholders' equity, FY2024, at 2024-12-31$5.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure(5.4)Shareholders' equity, Q1 FY2025, at 2025-03-31−$5.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure7.9Shareholders' equity, Q2 FY2025, at 2025-06-30$7.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure25.8Shareholders' equity, Q3 FY2025, at 2025-09-30$25.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure10.9Shareholders' equity, FY2025, at 2025-12-31$10.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure4.0Shareholders' equity, Q1 FY2026, at 2026-03-31$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure10.9Shareholders' equity, Q2 FY2026, at 2026-06-30$10.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure

Cash flow

Operating cash flow−$11.3m, Q2 FY2026
Capital expenditure$21.0k, Q2 FY2026
Lucid Diagnostics Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001493152-24-044799. Derived: 9-month figure less the 6-month figure.Report this figure(10.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$10.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0001641172-25-000205. Derived: 12-month figure less the 9-month figure.Report this figure(12.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure(11.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001493152-25-011862. Derived: 6-month figure less the 3-month figure.Report this figure(10.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021737. Derived: 9-month figure less the 6-month figure.Report this figure(9.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure(12.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(10.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001437749-26-027335. Derived: 6-month figure less the 3-month figure.Report this figure(10.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021737. Derived: 9-month figure less the 6-month figure.Report this figure(12.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001437749-26-009805. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure(11.3)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001437749-26-027335. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reported0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$93.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001437749-26-027335. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$215.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001437749-26-016751.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001437749-26-027335. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)108.18m, Q3 FY2025
Lucid Diagnostics Inc., shares, quarterly
Line itemUnitQ2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30
Diluted shares (weighted)m shares35.8Diluted shares (weighted), Q2 FY2022, three months to 2022-06-3035,760,492 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-14, accession 0001493152-23-028577.Report this figure36.4Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3036,405,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040623.Report this figure41.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3140,970,504 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001493152-24-018800.Report this figure41.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3041,833,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001493152-24-031168.Report this figure41.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3041,862,805 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001493152-24-044799.Report this figure45.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3145,014,410 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure48.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3048,212,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure50.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3050,374,146 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure68.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3168,796,392 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001641172-25-009986.Report this figure99.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3098,989,161 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001493152-25-011862.Report this figure108Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30108,176,088 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021737.Report this figure

Shares outstanding: 203.24mShares outstanding, period not labelled, at 2026-08-10203,243,970 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001437749-26-027335.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.